In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

Go on, give it a shot. Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

When it comes to weight loss journeys, we often focus on before-and-after photos and diet tips. But what happens when your ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...